Fig. 2

Expression status of miR-145: in a normal vs tumor breast cancer samples (p value < 0.01); b tumor samples grouped in stage 1 + 2 and stage 3 + 4 (p value < 0.001) and; c tumor samples grouped on the basis of number of nodes getting effected (p value < 0.05)